eHealth Project of the Month - SYMBIOmatics

ICT for HealthThe increasing convergence of biology, medicine and genetics provides an opportunity to leverage synergies between the three areas for the benefit of health. Biology and genetics are emerging as information sciences while medicine is increasingly adopting information systems and informatics approaches to support healthcare delivery.

Bioinformatics and medical (or health) informatics are both rapidly advancing fields. Advances in molecular biology and genetics are broadening the domain of bioinformatics to embrace the biology of cells, tissues, organs, organisms and populations. Within medicine, increasing understanding of the molecular basis of disease, and the effect of genotype on disease propensity and treatment efficacy, creates an opportunity for increased convergence between the disciplines and the leverage of synergies for the benefit of health.

The SYMBIOmatics Specific Support Action (SSA) is an information gathering and dissemination activity that was designed to identify and exploit synergies between bioinformatics and medical informatics as well as identifying addressable challenges for the medium term future. The project documented the state-of-the-art in biomedical informatics in Europe and identified prioritised areas of new opportunity.

The Information and Communication Technologies for BIO-medical Sciences in Brussels on 29th to 30th June 2006 presented the initial findings for discussion by the wider community of bioinformatician, medical informaticians, medical practitioners and policy makers. A White Paper summarising the findings is now available for download from http://www.symbiomatics.org.

The white paper identifies thirty-one areas of potential synergies, significantly more than in previous analyses suggesting a broadening the areas of synergy. The further indicated that much of the state of the art activity in Europe is being co-ordinated through EU or international projects - often in partnership with the new NLM National Centres of Biomedical Informatics in the USA, but typically not solely at the level of individual EU member states. This represents a maturing of the field as is indicate of the importance placed by funding organisations.

Through a process of facilitated workshops, and on-line consultation, stakeholders were asked to give preferences for the thirty-one areas in respect of three prioritisation criteria that are the appropriateness to be funded at a European level (EU funding), the likelihood of strong intermediate results (Impact), and the industry commitment/validation. The process and outcomes are described in detail in the white paper.

Objectives of the white paper
The objectives of the SYMBIOmatics' project are information gathering, prioritisation of oppotunities and the generation of recommendations for research actions in the area of biomedical informatics.

These objectives will contribute directly to the scientific, technical, wide societal and policy objectives of biomedical informatics. The societal opportunity associated with these advances dependent upon biomedical informatics relates to improved healthcare and well-being for EU citizens across all member states.

The synergies that emerge from the integration of these fields will enable more dynamic and faster breakthroughs in medicine and healthcare. This will have a direct societal impact on different stakeholders, including individual citizens, healthcare professionals, scientists, healthcare providers, policy and decision makers, industry, society, etc.

Research in identified areas
As result of the Symbiomatics process a list of high priority areas of research has been identified, such as Gene Expression Information in Medical Diagnostics & Prognostics, Modelling & Simulation of Biological Structures & Processes/Diseases, Integration of Data from Biosensors & Medical Devices with Clinical Information Systems, Integration of patient molecular data in Electronic Health Records, Semantic Interoperability and Ontologies in Biomedicine and Data Interoperability & Standards to name a few.

Benefits in supporting research - conclusions
From the study it emerges that there are many new and developing areas of synergy between bioinformatics and medical (or health) informatics, with significant potential benefits in the delivery of healthcare to citizens. Building on of the support already provided in the 6th Framework programme, the European Commission will continue to fund research focusing these high priority areas in the 7th FP.

Project website: http://www.symbiomatics.org

For further information:
ICT for Health
European Commission - Information society and Media DG
Office: BU31 06/73 B-1049 Brussels
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Tel: +32 2 296 41 94
Fax: +32 2 296 01 81
http://europa.eu/information_society/eHealth

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...